AI assistant
Sending…
Sunshine Biopharma Inc. — Director's Dealing 2012
Sep 7, 2012
35352_dirs_2012-09-07_18d33986-db6b-488d-b1ad-fbdd94a78432.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sunshine Biopharma, Inc (SBFM)
CIK: 0001402328
Period of Report: 2011-12-21
Reporting Person: Slilaty Steve N. (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-21 | Common Stock | C | 17000000 | — | Acquired | 34109194 | Indirect |
| 2012-09-04 | Common Stock | S | 2591500 | $0.05 | Disposed | 31517694 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-12-21 | Series A Preferred Stock | $0 | C | 17000000 | Disposed | 2034-10-15 | Common Stock (17000000) | Indirect |
More from Sunshine Biopharma Inc.
Share Issue/Capital Change
2026
May 29
Capital/Financing Update
2026
May 19
Share Issue/Capital Change
2026
May 19
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
Apr 9
Annual Report
2026
Apr 3
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 20
Board/Management Information
2026
Feb 5
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 12
Interim / Quarterly Report
2025
Nov 13